作者
Erika Petersen,Thomas Stauss,James Scowcroft,Michael J. Jaasma,Deborah Edgar,Judith L. White,Shawn Sills,Kasra Amirdelfan,Maged Guirguis,Jijun Xu,Cong Yu,Ali Nairizi,Denis Patterson,Michael Creamer,Vincent Galan,Richard Bundschu,Neel Mehta,Dawood Sayed,Shivanand P. Lad,David DiBenedetto,Khalid A. Sethi,Johnathan Goree,Matthew T. Bennett,Nathan J. Harrison,Atef F. Israel,Paul Chang,Peizhe Wu,Charles E. Argoff,Christian Nasr,Rod S Taylor,David Caraway,Nagy Mekhail
摘要
The SENZA-PDN study evaluated high-frequency 10-kHz spinal cord stimulation (SCS) for the treatment of painful diabetic neuropathy (PDN). Over 24 months, 10-kHz SCS provided sustained pain relief and improved health-related quality of life. This report presents additional outcomes from the SENZA-PDN study, focusing on diabetes-related pain and quality of life outcomes.